G Medical Innovations Stock EBITDA
G Medical Innovations fundamentals help investors to digest information that contributes to G Medical's financial success or failures. It also enables traders to predict the movement of GMVDW Stock. The fundamental analysis module provides a way to measure G Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to G Medical stock.
GMVDW |
G Medical Innovations Company EBITDA Analysis
G Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current G Medical EBITDA | (37.75 M) |
Most of G Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, G Medical Innovations is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, G Medical Innovations reported earnings before interest,tax, depreciation and amortization of (37.75 Million). This is 104.3% lower than that of the Health Care Equipment & Supplies sector and 108.02% lower than that of the Health Care industry. The ebitda for all United States stocks is 100.97% higher than that of the company.
GMVDW EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses G Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of G Medical could also be used in its relative valuation, which is a method of valuing G Medical by comparing valuation metrics of similar companies.G Medical is currently under evaluation in ebitda category among its peers.
GMVDW Fundamentals
| Return On Equity | -8.65 | |||
| Return On Asset | -1.26 | |||
| Operating Margin | (6.38) % | |||
| Revenue | 4.42 M | |||
| EBITDA | (37.75 M) | |||
| Net Income | (25.07 M) | |||
| Cash And Equivalents | 278 K | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 2.09 M | |||
| Current Ratio | 0.40 X | |||
| Book Value Per Share | (0.44) X | |||
| Cash Flow From Operations | (18.48 M) | |||
| Beta | -0.97 | |||
| Total Asset | 4.83 M | |||
| Retained Earnings | (115.26 M) | |||
| Working Capital | (7.12 M) | |||
| Z Score | -60.12 | |||
| Net Asset | 4.83 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in GMVDW Stock
If you are still planning to invest in G Medical Innovations check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the G Medical's history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |